在2型糖尿病中,Nrf2调节了晚上运动的益处
Babatunde Fasipe1, Ismail Laher2
1Faculty of Basic Clinical Sciences, Department of Pharmacology and Therapeutics, Bowen University, Iwo, Nigeria.
Sports medicine and health science
|February 5, 2024
概括
晚上运动通过在水平最低时激活核因素红色素2相关因子-2 (Nrf2),改善葡萄糖代谢,有利于2型糖尿病. 早晨炼可能会过度激活Nrf2,从而减少它对糖尿病管理的有益信号.
科学领域:
- * 时代生物学和运动生理学
- * 代谢疾病的分子机制
背景情况:
- * 运动对于管理2型糖尿病 (T2DM) 至关重要,其益处与核因素红色素2相关因子-2 (Nrf2) 激活有关.
- * Nrf2 调节细胞抗氧化能力和昼夜节律,影响葡萄糖代谢.
- * 运动的时间影响Nrf2激活及其节律信号,导致不同的生理效应.
研究的目的:
- * 调查运动时间不同影响Nrf2信号和T2DM管理的假设.
- * 探索运动诱导的Nrf2节律与改善的葡萄糖控制和脂肪酸氧化相关的机制.
主要方法:
- *对有关运动,Nrf2昼夜节律和T2DM的现有文献的综述.
- *对Nrf2表达模式的分析与运动时间 (早上与晚上) 相比.
- * 假设Nrf2激活在不同昼夜阶段对代谢结果的影响.
主要成果:
- *当Nrf2水平较低时,晚间运动被假定可以增强Nrf2信号传递,降低血糖,并增加脂肪酸氧化.
- *早晨运动,当Nrf2水平较高时,可能导致过度活化和减少Nrf2信号效益.
- * 运动的不同生理效应与Nrf2活动的昼夜节律有关.
结论:
- * 运动时间显著影响Nrf2激活及其在T2DM中的治疗效果.
- * 晚间运动有望改善T2DM的血糖控制和代谢参数.
- * 了解Nrf2节奏性可以优化运动时间和Nrf2激活剂的应用,用于T2DM治疗.
相关概念视频
Type I Diabetes II: Pathophysiology
75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28


